Financed by venture capitalists and backed by a board of marquee scientists, Elysium Health executives scored a key negotiation tool with chemical giant W.R. Grace in 2016: a confidential sales spreadsheet from Elysium's then-supplier that showed Elysium was the dominate purchaser of a key ingredient in anti-aging supplements.